Hanling Wang

发表

ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression

G. Hu, Qintong Li, Minjia Tan, 2022, Nature Communications.

Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition

Yingming Zhao, Junmei Zhang, Ying Jin, 2018, Stem cell reports.

SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.

Jian Zhang, J. Qin, K. Song, 2020, Cancer cell.

CDK11 safeguards the identity of human embryonic stem cells via fine‐tuning signaling pathways

Rong Zeng, Zhexin Zhu, Ying Jin, 2020, Journal of cellular physiology.

Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-γ–stimulated antitumor immunity

G. Hu, Qintong Li, Minjia Tan, 2022, The Journal of clinical investigation.

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.

J. Qin, Qintong Li, Minjia Tan, 2021, Molecular cell.

Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer.

Zhengquan Yu, Minjia Tan, B. Dong, 2023, Cancer cell.

GATA2 promotes castration-resistant prostate cancer development by suppressing IFN-β axis-mediated antitumor immunity.

Hanling Wang, Zige Jin, Mafei Xu, 2024, Oncogene.

Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Minjia Tan, Yanqing Wang, B. Dong, 2024, Nature cancer.